StockGlow

BioMarin Pharmaceutical Inc. (0HNC.L)

BioMarin Pharmaceutical Inc., a biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

$60.41-0.02%
Compare 0HNC.L with
StockGlow Score
4
Bearish
BearishBullish
1 year ago+4.4%

The outlook

BioMarin Pharmaceutical Inc. currently reads as bearish based on below its 50- & 200-day averages, 1% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range1% of the way from its 52-week low to high
Market cap
—
52-wk high
$99.65
52-wk low
$59.89
50-day avg
$90.32
200-day avg
$89.61
Trailing P/E
2.8

Similar stocks

0M30.LYum China Holdings, Inc.$46.30+0.39%0JT5.LLam Research Corporation$295.88+13.49%0K36.LMoody's Corporation$479.50-1.26%0R0H.LThermo Fisher Scientific Inc.$570.91-0.21%0KNY.LT. Rowe Price Group, Inc.$119.41-0.49%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy